IPO Guru
Bajaj
Listed Mainboard

Prasol Chemicals IPO Review

Prasol Chemicals IPO has been reviewed by 12 analysts, and the overall consensus is Apply — carrying a score of 81. Out of the 12 analysts who have covered this IPO, 8 recommend subscribing while 4 advise caution or avoidance — reflecting a broadly positive view from the analyst community.

The issue is priced in the band of ₹643-676 per share, with a minimum application size of 22 shares (minimum investment of approximately ₹14,872 at the upper band). Subscription ran from 08 Sep 2026 to 10 Sep 2026. The issue size is ₹500 crore, a mix of fresh issue and offer for sale. As of now, the grey market premium (GMP) for Prasol Chemicals IPO is quoting at ₹-13 (-1.92%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Analyst verdict & score

One score out of 100, aggregated from every analyst verdict tracked for this issue. How it's calculated

Sentiment score
81/ 100
Apply 8 of 12 recommend subscribing
How analysts voted
Apply 8
May apply 2
Neutral 1
Avoid 1
Not rated 1

Higher consensus indicates broader analyst agreement.

Detailed review

What the analyst reports say, grouped by the question you're likely asking.

General review

Prasol Chemicals, incorporated in 1992 and based in Navi Mumbai, makes over 150 acetone-based, phosphorous-based and complex specialty chemicals for the paints, pharmaceutical, agrochemical and personal care industries, serving 1,618 customers across 69 countries. FY26 income was ₹1,237.85 crore with profit of ₹83.12 crore. Seven of the nine analysts said subscribe, one stayed neutral.

Listing gains

The notes cluster the valuation between about 47 and 48.1 times FY26 earnings on post-issue capital. That is a full multiple in absolute terms, and analysts justify it on the pace of profit growth rather than on any discount to peers. The lone neutral rating reflects exactly that, pointing to a moderate listing.

Short-term strategy

Profit nearly doubled in FY26, from ₹43.57 crore to ₹83.12 crore, with EBITDA rising to ₹139.32 crore on 22 percent revenue growth. One note describes the growth as genuinely accelerating. Fresh money repays ₹60 crore of borrowings, though most of the issue, ₹420 crore, is an offer for sale.

Long-term strategy

Several analysts assign explicitly long-term ratings, citing three decades of experience, a broad product range, marquee customers including Alembic, Lubrizol and Clean Science, and low customer concentration at 23.68 percent from the top ten. The standing risk is operational: both plants have faced pollution control shutdowns, including a Mahad closure from October 2023 to May 2024.

How this is written: an AI-assisted summary of the 13 analyst reports listed below. It reports their views; IPO Guru does not make buy or sell recommendations.

Analyst reviews

Ordered by each analyst's track record over the past year; analysts still building one are listed last.

Latest IPO reviews

How analysts rated the most recent mainboard issues — and, where they have listed, how the call played out.

Frequently asked

Should I apply for Prasol Chemicals IPO?

The analyst consensus for Prasol Chemicals IPO tracked on this page is Apply, with a score of 81/100. Out of 12 analysts who have reviewed this IPO, 8 recommend subscribing. IPO Guru does not make buy or sell recommendations. Read the individual analyst reports and consult a SEBI-registered advisor before investing.

What does the score of 81 mean for Prasol Chemicals IPO?

The score of 81 is an aggregate of all analyst ratings tracked for Prasol Chemicals IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Read the individual analyst verdicts above for more context.

What was the actual listing price of Prasol Chemicals IPO?

Prasol Chemicals IPO listed on September 16, 2026 at ₹610, against the issue price of ₹676 — a loss of -9.76% (₹66 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Prasol Chemicals IPO?

Prasol Chemicals IPO was priced at ₹643-676 per share. The minimum lot size is 22 shares, making the minimum investment approximately ₹14,872 at the upper end of the price band. Subscription ran from 08 Sep 2026 to 10 Sep 2026.

Explore Prasol Chemicals IPO further

Analyst views are one input. Read them alongside the demand, the grey market and the filings before you decide.

Prasol Chemicals IPO review

A verdict is an opinion, not a guarantee.

IPO Guru collects analyst views, GMP, subscription and allotment for every Mainboard and SME issue. Weigh them together — and against the offer document — before you apply.

Join the WhatsApp channel Full IPO details

Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.

Consensus
Apply
Score
81 / 100
Listed at
₹610
Full IPO details